Results 11 to 20 of about 87,105 (259)

Is treatment resistant depression a different subtype of depression?

open access: yesEuropean Psychiatry, 2021
Major depression is a serious, disabling, often chronic or recurrent mental disorder affecting over 350 million people worldwide. Treatment of major depression is now conceptualized as proceeding through three phases: the acute phase, the continuation ...
A. Fiorillo
doaj   +1 more source

Modeling treatment-resistant depression [PDF]

open access: yesNeuropharmacology, 2011
Depression is a polygenic and highly complex psychiatric disorder that is currently a major burden on society. Depression is highly heterogeneous in presentation and frequently exhibits high comorbidity with other psychiatric and somatic disorders. Commonly used treatments, such as selective serotonin reuptake inhibitors (SSRIs), are not ideal since ...
Benjamin Adam, Samuels   +8 more
openaire   +2 more sources

Use of pharmacotherapies for treatment resistant depression in finland: A nationwide cohort study

open access: yesEuropean Psychiatry, 2021
Introduction There is a lack of knowledge on utilized pharmacotherapies for treatment resistant depression (TRD). Objectives To investigate the courses of treatment of TRD.
H. Taipale   +4 more
doaj   +1 more source

Patients’ Comprehension of Mindfulness-Based Cognitive Behavioral Therapy in an Outpatient Clinic for Resistant Depression: A Cross-Sectional Study

open access: yesFrontiers in Psychology, 2019
The current study investigated the comprehension of mindfulness-based cognitive behavioral therapy (MBCT) by patients with resistant depression at the Psychiatry Institute of the Federal University of Rio de Janeiro, Brazil.
Michele F. Rodrigues   +7 more
doaj   +1 more source

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.

open access: yesPLoS ONE, 2020
ObjectiveThe economic burden of commercially insured patients in the United States with treatment-resistant depression and patients with non-treatment-resistant major depressive disorder was compared using data from the Optum Clinformatics™ claims ...
Gang Li   +7 more
doaj   +2 more sources

A study of remitted and treatment-resistant depression using MMPI and including pessimism and optimism scales. [PDF]

open access: yesPLoS ONE, 2014
The psychological aspects of treatment-resistant and remitted depression are not well documented.We administered the Minnesota Multiphasic Personality Inventory (MMPI) to patients with treatment-resistant depression (n = 34), remitted depression (n = 25),
Masatoshi Suzuki   +5 more
doaj   +1 more source

Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?

open access: yesJournal of Affective Disorders Reports, 2021
Objective: In a retrospective study, we analyzed if anxious depression impacts outcomes in patients with treatment resistant depression (TRD) receiving IV Ketamine infusions at an academic center Ketamine clinic.
Zoe Schreiber   +7 more
doaj   +1 more source

Treatment-Resistant Depression in the Elderly

open access: yesInternational Psychogeriatrics, 1995
Apparent treatment-resistant depression (TRD) is frequently encountered by and poses particular challenges for the old-age psychiatrist. The prevalence of true nonresponse to treatment is not known with accuracy but reports put it at 18% to 40% for the elderly.
D, Bonner, R, Howard
openaire   +2 more sources

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression

open access: yesPharmaceuticals, 2023
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with
Courtney M. Vecera   +4 more
doaj   +1 more source

Metyrapone in treatment-resistant depression [PDF]

open access: yesTherapeutic Advances in Psychopharmacology, 2012
Depression affects a significant proportion of the population, with 1-year and lifetime prevalence of 3–5% and 10–30% respectively. Full remission is achieved in only a third of patients following treatment with first-line antidepressant. There is a need for novel treatments for treatment-resistant depression (TRD).
Paul David, Sigalas   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy